Good to see MUE holding strong in this market - especially considering the European link. It appears a few others have woken up to this bargain.Does anyone have an idea when the amount of the special distribution will be decided?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%